Wouter De Graaff

Wouter de Graaff is an experienced pharmaceutical executive currently serving as Vice President of R&D at Sever Pharma Solutions. With expertise in controlled release drug delivery, Wouter has successfully managed the development of multiple drug applications and has played key roles in regulatory processes for novel dosage forms and drug-device combination products. Previously, Wouter held significant positions at Merck and NV Organon, where notable achievements included developing the NuvaRing® manufacturing process. Wouter's academic background includes a Master’s Degree in Chemical Engineering from the Universiteit van Amsterdam and advanced studies in Strategic R&D Management at INSEAD.